American Society of Hirudotherapy

Medicinal Leech Therapy in Acute Herpes Zoster Condition- A Case Report

Itankar PB, Sawarkar GR, Chakole DA (2025) · Journal of Pharmacy & Bioallied Sciences · 1 patient

Case-level evidence: Limited human evidence exists (small trials, case series, or pilot studies). Use is investigational and should be considered carefully under clinician guidance.Study record: Content describes science, methodology, or organizational reference material — not a clinical efficacy claim.

Study Profile

Design
single-patient Ayurveda case report of medicinal leech therapy combined with internal Ayurvedic formulation for acute herpes zoster (Mahatma Gandhi Ayurved College Hospital and Research Centre, Datta Meghe Institute of Higher Education and Research, Wardha, Maharashtra, India)
Patient
1
Presentation and intervention
Prompt leech therapy performed as emergency intervention plus internal Ayurvedic medication for 10 days in a 26-year-old male with acute herpes zoster (reddish rashes and small vesicular eruption over left lateral chest aspect with burning sensation and pain)
Outcome
Combined leech therapy and Ayurvedic internal medication regimen produced effective resolution of acute herpes zoster symptoms over 10 days; case concludes that leech therapy and Ayurvedic internal medicine constitute an effective management approach for acute herpes zoster
Follow-up duration
10 days of combined treatment

Key Findings

  • Documents combined leech therapy and Ayurvedic internal medicine for acute herpes zoster in an Indian academic Ayurveda center
  • Adds acute herpes zoster to the broader catalog of off-label leech-therapy indications in Ayurvedic practice
  • Reports clinical resolution of vesicular eruption, burning sensation, and pain over a 10-day combined regimen
  • Provides preliminary signal for future investigation of leech-derived antiviral or analgesic adjunctive approaches in herpes zoster

Limitations

  • Single case (n=1) - cannot establish efficacy or generalizability
  • Combined intervention (leech therapy plus internal Ayurvedic medicine) precludes attribution to leech therapy alone
  • No long-term follow-up to assess postherpetic neuralgia prevention
  • Patient demographics limited to a single 26-year-old male - other populations untested
  • Selection bias - successful case reports tend to be over-represented in case literature

Clinical Implications

Itankar 2025 is a single Ayurveda case report documenting that medicinal leech therapy combined with internal Ayurvedic medication may be useful in acute herpes zoster management. For US clinicians, the case does not change practice — leech therapy is not first-line or evidence-supported for acute herpes zoster — but does illustrate the breadth of off-label CAM applications. The case is included in the registry to document the cross-cultural utilization landscape of leech therapy, with appropriate caveats about the case-report evidence level.

Related studies

This website provides educational information and does not constitute medical advice, diagnosis, or treatment recommendations. Medicinal leech therapy carries clinically meaningful risks and should be performed only by qualified clinicians under institutionally approved protocols. FDA 510(k) clearance for medicinal leeches is limited to specific indications; investigational and off-label discussions are labeled accordingly. For patient-specific guidance, consult a qualified healthcare provider.